These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29455565)

  • 1. Pulsed dye laser versus intense pulsed light in melasma: a split-face comparative study.
    Hassan AM; Elfar NN; Rizk OM; Eissa NY
    J Dermatolog Treat; 2018 Nov; 29(7):725-732. PubMed ID: 29455565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
    Geddes ER; Stout AB; Friedman PM
    Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma.
    Vachiramon V; Sirithanabadeekul P; Sahawatwong S
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1339-46. PubMed ID: 25413592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential treatment with triple combination cream and intense pulsed light is more efficacious than sequential treatment with an inactive (control) cream and intense pulsed light in patients with moderate to severe melasma.
    Goldman MP; Gold MH; Palm MD; Colón LE; Preston N; Johnson LA; Gottschalk RW
    Dermatol Surg; 2011 Feb; 37(2):224-33. PubMed ID: 21269349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of autologous platelet-rich-plasma versus its combination with intense pulsed light in treatment of melasma.
    Adel S; Serri A; Abd El-Raheem T
    Dermatol Ther; 2021 Jul; 34(4):e15008. PubMed ID: 34041826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective analysis for facial telangiectasia treatment using pulsed dye laser and intense pulsed light configured with different wavelength bands.
    Gao L; Qu H; Gao N; Li K; Dang E; Tan W; Wang G
    J Cosmet Dermatol; 2020 Jan; 19(1):88-92. PubMed ID: 31638320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IPL vs PDL in treatment of facial erythema: A split-face study.
    Handler MZ; Bloom BS; Goldberg DJ
    J Cosmet Dermatol; 2017 Dec; 16(4):450-453. PubMed ID: 28752575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulse in pulse intense pulsed light for melasma treatment: a pilot study.
    Chung JY; Choi M; Lee JH; Cho S; Lee JH
    Dermatol Surg; 2014 Feb; 40(2):162-8. PubMed ID: 24433388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, split-face, randomized study of the efficacy and safety of a novel fractionated intense pulsed light treatment for melasma in Asians.
    Yun WJ; Lee SM; Han JS; Lee SH; Chang SY; Haw S; Lee JB; Won CH; Lee MW; Choi JH; Chang SE
    J Cosmet Laser Ther; 2015; 17(5):259-66. PubMed ID: 25803571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
    Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
    Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety comparison between pulsed dye laser and intense pulsed light configured with different wavelength bands in treating erythematotelangiectatic rosacea.
    Ruan J; Zheng Y; Cai S
    Lasers Med Sci; 2024 Jun; 39(1):146. PubMed ID: 38822948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-session intense pulsed light combined with stable fixed-dose triple combination topical therapy for the treatment of refractory melasma.
    Figueiredo Souza L; Trancoso Souza S
    Dermatol Ther; 2012; 25(5):477-80. PubMed ID: 23046029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of energy-based devices combination therapy for melasma.
    Iranmanesh B; Khalili M; Mohammadi S; Amiri R; Aflatoonian M
    Dermatol Ther; 2021 May; 34(3):e14927. PubMed ID: 33665885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Split-face treatment of facial dyschromia: pulsed dye laser with a compression handpiece versus intense pulsed light.
    Galeckas KJ; Collins M; Ross EV; Uebelhoer NS
    Dermatol Surg; 2008 May; 34(5):672-80. PubMed ID: 18318731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser.
    Cho HH; Choi M; Cho S; Lee JH
    J Dermatolog Treat; 2013 Aug; 24(4):292-6. PubMed ID: 22103770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea.
    Neuhaus IM; Zane LT; Tope WD
    Dermatol Surg; 2009 Jun; 35(6):920-8. PubMed ID: 19397667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Intense Pulsed Light versus Intradermal Tranexamic Acid for the Management of Melasma.
    Asim SA; Iqbal T; Sajid M; Bhatti S
    J Coll Physicians Surg Pak; 2024 May; 34(5):522-526. PubMed ID: 38720210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Split-face randomized treatment of facial telangiectasia comparing pulsed dye laser and an intense pulsed light handpiece.
    Tanghetti EA
    Lasers Surg Med; 2012 Feb; 44(2):97-102. PubMed ID: 22180317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of pulsed dye laser versus intense pulsed light in the treatment of striae distensae.
    Shokeir H; El Bedewi A; Sayed S; El Khalafawy G
    Dermatol Surg; 2014 Jun; 40(6):632-40. PubMed ID: 24852467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomized comparative study on 60 Indian patients of melasma, comparing pixel Q-switched NdYAG (1064 nm), super skin rejuvenation (540 nm) and ablative pixel erbium YAG (2940 nm) lasers, with a review of the literature.
    Garg S; Vashisht KR; Makadia S
    J Cosmet Laser Ther; 2019 Aug; 21(5):297-307. PubMed ID: 31010346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.